Jason Shafrin

1.3k total citations
84 papers, 848 citations indexed

About

Jason Shafrin is a scholar working on Economics and Econometrics, Family Practice and General Health Professions. According to data from OpenAlex, Jason Shafrin has authored 84 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Economics and Econometrics, 13 papers in Family Practice and 12 papers in General Health Professions. Recurrent topics in Jason Shafrin's work include Health Systems, Economic Evaluations, Quality of Life (32 papers), Economic and Financial Impacts of Cancer (14 papers) and Medication Adherence and Compliance (13 papers). Jason Shafrin is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (32 papers), Economic and Financial Impacts of Cancer (14 papers) and Medication Adherence and Compliance (13 papers). Jason Shafrin collaborates with scholars based in United States, United Kingdom and Switzerland. Jason Shafrin's co-authors include Dana P. Goldman, Darius Lakdawalla, Katalin Bognar, Jeffrey Trocio, Younos Abdulsattar, Daniel Wiederkehr, Mintu P. Turakhia, Felicia Forma, Thomas M. Gill and Amitabh Chandra and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jason Shafrin

74 papers receiving 827 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason Shafrin United States 15 279 191 131 93 89 84 848
Andrew Toren Canada 6 277 1.0× 131 0.7× 103 0.8× 46 0.5× 43 0.5× 10 840
Bente Glintborg Denmark 26 141 0.5× 64 0.3× 76 0.6× 83 0.9× 87 1.0× 109 2.3k
Lauren Gilstrap United States 14 203 0.7× 350 1.8× 226 1.7× 33 0.4× 80 0.9× 44 916
Marc H. Hemmelder Netherlands 19 148 0.5× 306 1.6× 141 1.1× 58 0.6× 56 0.6× 71 1.2k
Steve Arcona United States 13 87 0.3× 128 0.7× 186 1.4× 102 1.1× 32 0.4× 30 798
Jamie Roberts United States 11 188 0.7× 111 0.6× 239 1.8× 83 0.9× 39 0.4× 24 941
Andrew M. Peterson United States 8 177 0.6× 99 0.5× 69 0.5× 90 1.0× 36 0.4× 14 718
Márcio Machado Canada 15 141 0.5× 87 0.5× 87 0.7× 51 0.5× 161 1.8× 23 905
Holly Van Houten United States 17 118 0.4× 199 1.0× 236 1.8× 32 0.3× 82 0.9× 31 806
Safiya Abouzaid United States 16 164 0.6× 62 0.3× 52 0.4× 92 1.0× 250 2.8× 41 971

Countries citing papers authored by Jason Shafrin

Since Specialization
Citations

This map shows the geographic impact of Jason Shafrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Shafrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Shafrin more than expected).

Fields of papers citing papers by Jason Shafrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Shafrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Shafrin. The network helps show where Jason Shafrin may publish in the future.

Co-authorship network of co-authors of Jason Shafrin

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Shafrin. A scholar is included among the top collaborators of Jason Shafrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Shafrin. Jason Shafrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Shafrin, Jason, et al.. (2025). Two Approaches for Measuring Treatment Value Under Uncertainty: Estimating Insurance Value and Risk Preferences in Neurology. Forum for Health Economics & Policy. 28(1). 21–42.
5.
Shafrin, Jason, et al.. (2025). Economic impact of sotagliflozin among patients with heart failure and type 2 diabetes: Budget impact analysis from the US payer perspective. Journal of Managed Care & Specialty Pharmacy. 31(4). 386–395.
6.
7.
Shafrin, Jason, et al.. (2024). Quantifying the financial impact of treatment intolerance in chronic myeloid leukemia on oncology clinical practices: A mixed methods study.. Journal of Clinical Oncology. 42(16_suppl). e18520–e18520. 1 indexed citations
8.
9.
10.
Shafrin, Jason, et al.. (2023). A Decade of Health Innovation: The Impact of New Medicines on Patient Health and the Implications for NICE’s Size of Benefit Multiplier. Value in Health. 26(10). 1435–1439. 1 indexed citations
11.
Shafrin, Jason, et al.. (2023). Wound-Specific Oral Nutritional Supplementation Can Reduce the Economic Burden of Pressure Injuries for Nursing Homes: Results from an Economic Model. SHILAP Revista de lepidopterología. 166–177. 1 indexed citations
12.
Shafrin, Jason, et al.. (2023). P1 Quantifying the Insurance and Altruism Value for Rare Diseases: A Case Study for Duchenne Muscular Dystrophy. Value in Health. 26(6). S1–S1. 3 indexed citations
13.
Halasy, Michael & Jason Shafrin. (2021). When Should You Trust Your Doctor? Establishing a Theoretical Model to Evaluate the Value of Second Opinion Visits. SHILAP Revista de lepidopterología. 5(2). 502–510. 2 indexed citations
14.
Shafrin, Jason, Howard Thom, Edna Keeney, et al.. (2021). The impact of vaso-occlusive crises and disease severity on quality of life and productivity among patients with sickle cell disease in the US. Current Medical Research and Opinion. 37(5). 761–768. 6 indexed citations
15.
Shafrin, Jason, Suepattra G. May, Katalin Bognar, et al.. (2021). Measuring the Value Healthy Individuals Place on Generous Insurance Coverage of Severe Diseases: A Stated Preference Survey of Adults Diagnosed With and Without Lung Cancer. Value in Health. 24(6). 855–861. 7 indexed citations
16.
May, Suepattra G., Caroline Huber, Jason Shafrin, et al.. (2021). Adoption of Digital Health Technologies in the Practice of Behavioral Health: Qualitative Case Study of Glucose Monitoring Technology. Journal of Medical Internet Research. 23(2). e18119–e18119. 8 indexed citations
17.
Thom, Howard, Jeroen P. Jansen, Jason Shafrin, et al.. (2020). Crizanlizumab and comparators for adults with sickle cell disease: a systematic review and network meta-analysis. BMJ Open. 10(9). e034147–e034147. 8 indexed citations
18.
Shafrin, Jason, et al.. (2017). The cost of adherence mismeasurement in serious mental illness: a claims-based analysis.. PubMed. 23(5). e156–e163. 9 indexed citations
19.
Bognar, Katalin, et al.. (2017). Value-Based Payments and Incentives to Improve Care: A Case Study of Patients with Type 2 Diabetes in Medicare Advantage. Value in Health. 20(8). 1216–1220. 1 indexed citations
20.
Shafrin, Jason, et al.. (2016). Use of Net Monetary Benefit Analysis to Comprehensively Understand the Value of Innovative Treatments. Value in Health. 19(7). A731–A731. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew Toren Breakdown of academic impact, for papers by Bente Glintborg Breakdown of academic impact, for papers by Lauren Gilstrap Breakdown of academic impact, for papers by Marc H. Hemmelder Breakdown of academic impact, for papers by Steve Arcona Breakdown of academic impact, for papers by Jamie Roberts Breakdown of academic impact, for papers by Andrew M. Peterson Breakdown of academic impact, for papers by Márcio Machado Breakdown of academic impact, for papers by Holly Van Houten Breakdown of academic impact, for papers by Safiya Abouzaid
Rankless by CCL
2026